4//SEC Filing
Poole Sandra 4
Accession 0001209191-21-033846
CIK 0001438533other
Filed
May 17, 8:00 PM ET
Accepted
May 18, 9:13 PM ET
Size
7.3 KB
Accession
0001209191-21-033846
Insider Transaction Report
Form 4
Poole Sandra
Director
Transactions
- Award
Stock option (right to buy)
2021-05-14+9,000→ 9,000 totalExercise: $18.27From: 2022-05-14Exp: 2031-05-13→ Common Stock (9,000 underlying) - Award
Common Stock
2021-05-14+3,000→ 9,500 total
Footnotes (2)
- [F1]Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program.
- [F2]The equity award vests over a one year period.
Documents
Issuer
Travere Therapeutics, Inc.
CIK 0001438533
Entity typeother
Related Parties
1- filerCIK 0001619622
Filing Metadata
- Form type
- 4
- Filed
- May 17, 8:00 PM ET
- Accepted
- May 18, 9:13 PM ET
- Size
- 7.3 KB